PI3K in stemness regulation: from development to cancer. (2020)
Attributed to:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bst20190778
PubMed Identifier: 32010943
Publication URI: http://europepmc.org/abstract/MED/32010943
Type: Journal Article/Review
Volume: 48
Parent Publication: Biochemical Society transactions
Issue: 1
ISSN: 0300-5127